IsoRay, Inc. (DE) (ISR): Price and Financial Metrics
ISR Price/Volume Stats
Current price | $0.38 | 52-week high | $0.45 |
Prev. close | $0.38 | 52-week low | $0.19 |
Day low | $0.36 | Volume | 145,000 |
Day high | $0.39 | Avg. volume | 290,697 |
50-day MA | $0.32 | Dividend yield | N/A |
200-day MA | $0.33 | Market Cap | 54.57M |
ISR Stock Price Chart Interactive Chart >
IsoRay, Inc. (DE) (ISR) Company Bio
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company produces CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers, as well as ocular melanoma. It sells its products to facilities or physician practices that utilize multiple surgical facilities at which primarily prostate brachytherapy procedures are performed. Isoray, Inc. was founded in 1998 and is headquartered in Richland, Washington.
ISR Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | -25.20% |
5-year | -15.56% |
YTD | N/A |
2023 | 0.00% |
2022 | -36.28% |
2021 | -13.82% |
2020 | -27.93% |
2019 | 108.13% |
Continue Researching ISR
Want to do more research on Isoray Inc's stock and its price? Try the links below:Isoray Inc (ISR) Stock Price | Nasdaq
Isoray Inc (ISR) Stock Quote, History and News - Yahoo Finance
Isoray Inc (ISR) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...